Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 16, 2020 - Issue 7: Asia Endemic Diseases
Submit an article Journal homepage
3,286
Views
11
CrossRef citations to date
0
Altmetric
Research Paper

Estimating the population health and economic impacts of introducing a pneumococcal conjugate vaccine in Malaysia- an economic evaluation

Asrul Akmal Shafiea School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, MalaysiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-5629-9270View further author information
ORCID Icon,
Norazah Ahmadb Institute for Medical Research, Ministry of Health, Kuala Lumpur, MalaysiaView further author information
,
Jerusha Naidooc Medical and Scientific Affairs, Pfizer Malaysia Sdn Bhd, Kuala Lumpur, MalaysiaView further author information
,
Chee Yoong Food Real World Insights, IQVIA Asia Pacific, Petaling Jaya, MalaysiaORCID Iconhttps://orcid.org/0000-0002-1833-4290View further author information
ORCID Icon,
Callix Wongd Real World Insights, IQVIA Asia Pacific, Petaling Jaya, MalaysiaORCID Iconhttps://orcid.org/0000-0002-0924-8139View further author information
ORCID Icon,
Sarah Pughe Health Economics and Outcomes Research, Pfizer Inc, Collegeville, PA, USAORCID Iconhttps://orcid.org/0000-0003-4347-2561View further author information
ORCID Icon &
Kah Kee Tanf Tuanku Ja’afar Hospital, Seremban, MalaysiaView further author information
 show all
Pages 1719-1727 | Received 29 Aug 2019, Accepted 04 Dec 2019, Published online: 17 Jan 2020

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

JP Sevilla, Daria Burnes, Rehab Zakaria El Saie, Hammam Haridy, Matt Wasserman, Sarah Pugh, Johnna Perdrizet & David Bloom. (2022) Cost-utility and cost-benefit analysis of pediatric PCV programs in Egypt. Human Vaccines & Immunotherapeutics 18:6.
Read now
Johnna Perdrizet, Carlos Felipe S. Santana, Thais Senna, Rodrigo Fernandes Alexandre, Rodrigo Sini de Almeida, Julia Spinardi & Matt Wasserman. (2022) Reply letter to “response to article by Johnna Perdrizet et al.” by Gomez and colleagues. Human Vaccines & Immunotherapeutics 18:1.
Read now
Johnna Perdrizet, Carlos Felipe S. Santana, Thais Senna, Rodrigo Fernandes Alexandre, Rodrigo Sini de Almeida, Julia Spinardi & Matt Wasserman. (2021) Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants. Human Vaccines & Immunotherapeutics 17:4, pages 1162-1172.
Read now

Articles from other publishers (8)

Alex J. J. Lister, Evelin Dombay, David W. Cleary, Lokman H. Sulaiman & Stuart C. Clarke. (2023) A brief history of and future prospects for pneumococcal vaccination in Malaysia. Pneumonia 15:1.
Crossref
Michele Wilson, Cheryl McDade, Anna Trisia Beby-Heijtel, Angela Waterval-Overbeek, Vishalini Sundaram & Johnna Perdrizet. (2023) Assessing Public Health Impact of Four Pediatric Pneumococcal Conjugate Vaccination Strategies in the Netherlands. Infectious Diseases and Therapy 12:7, pages 1809-1821.
Crossref
Nurul Asyikin Abdul Rahman, Mohd Nasir Mohd Desa, Siti Norbaya Masri, Niazlin Mohd Taib, Nurshahira Sulaiman, Hazmin Hazman & James John. (2023) The Molecular Approaches and Challenges of Streptococcus pneumoniae Serotyping for Epidemiological Surveillance in the Vaccine Era . Polish Journal of Microbiology 72:2, pages 103-115.
Crossref
M. Sakil Syeed, Priyanka Ghule, Lan M. Le, Sajesh K. Veettil, Emily K. Horn, Johnna Perdrizet, Matt Wasserman, Ammarin Thakkinstian & Nathorn Chaiyakunapruk. (2023) Pneumococcal Vaccination in Children: A Systematic Review and Meta-Analysis of Cost-Effectiveness Studies. Value in Health 26:4, pages 598-611.
Crossref
Johnna Perdrizet, Emily Horn, Winniefer Nua, Judith Perez-Peralta, Jennifer Nailes, Jaime Santos & Anna Ong-Lim. (2022) Response to Gomez et al.’s Letter to the Editor Regarding: “Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants”. Infectious Diseases and Therapy.
Crossref
Alex J. J. Lister, Cheng Foh Le, Eddy Seong Guan Cheah, Mohd Nasir Mohd Desa, David W. Cleary & Stuart C. Clarke. (2021) Serotype distribution of invasive, non-invasive and carried Streptococcus pneumoniae in Malaysia: a meta-analysis. Pneumonia 13:1.
Crossref
Johnna Perdrizet, Emily K. Horn, Winniefer Nua, Judith Perez-Peralta, Jennifer Nailes, Jaime Santos & Anna Ong-Lim. (2021) Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants. Infectious Diseases and Therapy 10:4, pages 2625-2642.
Crossref
Michele R. Wilson, Cheryl L. McDade, Johnna E. Perdrizet, Annick Mignon, Raymond A. Farkouh & Matt D. Wasserman. (2021) Validation of a Novel Forecasting Method for Estimating the Impact of Switching Pneumococcal Conjugate Programs: Evidence from Belgium. Infectious Diseases and Therapy 10:3, pages 1765-1778.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.